Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-03-07 @ 9:29 PM
Study NCT ID:
NCT05447494
Status:
UNKNOWN
Last Update Posted:
2022-07-27
First Post:
2022-07-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease
Sponsor:
CANbridge (Suzhou) Bio-pharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAN103-GD-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None